Misinterpretation of TPMT by a DTC Genetic Testing CompanyBROWNSTEIN, C. A; MARGULIES, D. M; MANZI, S. F et al.Clinical pharmacology and therapeutics. 2014, Vol 95, Num 6, pp 598-600, issn 0009-9236, 3 p.Article

Direct-to-Consumer Genetic Testing: Failure Is Not an OptionALTMAN, R. B.Clinical pharmacology and therapeutics. 2009, Vol 86, Num 1, pp 15-17, issn 0009-9236, 3 p.Article

Preimplantation genetic testingBREZINA, Paul R; BREZINA, Dawn S; KEARNS, William G et al.BMJ (Overseas and retired doctors ed.). 2012, Vol 345, Num 7875, pp 38-43, issn 1759-2151, 6 p.Article

Use and misuse of preimplantation genetic testingBRAUDE, Peter; FLINTER, Frances.BMJ. British medical journal (International ed.). 2007, Vol 335, Num 7623, pp 752-754, issn 0959-8146, 3 p.Article

Direct-to-Consumer Genetic Testing: The Need to Get Retail Genomics RightSCHICKEDANZ, A. D; HERDMAN, R. C.Clinical pharmacology and therapeutics. 2009, Vol 86, Num 1, pp 17-20, issn 0009-9236, 4 p.Article

23andMe, the Food and Drug Administration, and the Future of Genetic TestingZETTLER, Patricia J; SHERKOW, Jacob S; GREELY, Henry T et al.JAMA internal medicine (Print). 2014, Vol 174, Num 4, pp 493-494, issn 2168-6106, 2 p.Article

THE CULTURAL PARADOX OF PREDICTIVE GENETIC TESTING FOR HUNTINGTON'S DISEASE = LE PARADOXE CULTUREL DU DÉPISTAGE GÉNÉTIQUE PREDICTIF POUR LA MALADIE DE HUNTINGTONHAGEN, Niclas.Ethnologia Europaea. 2013, Vol 43, Num 1, pp 55-67, issn 0425-4597, 13 p.Article

Developing and Validating Continuous Genomic Signatures in Randomized Clinical Trials for Predictive MedicineMATSUI, Shigeyuki; SIMON, Richard; PINGPING QU et al.Clinical cancer research (Print). 2012, Vol 18, Num 21, pp 6065-6073, issn 1078-0432, 9 p.Article

Toward theragnosticsPENE, Frédéric; COURTINE, Emilie; CARIOU, Alain et al.Critical care medicine. 2009, Vol 37, Num 1, issn 0090-3493, S50-S58, SUPConference Paper

Use of Contemporary Genetics in Cardiovascular DiagnosisGEORGE, Alfred L.Circulation (New York, N.Y.). 2014, Vol 130, Num 22, pp 1971-1980, issn 0009-7322, 10 p.Article

The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary Syndromes: A New Zealand EvaluationPANATTONI, Laura; BROWN, Paul M; TE AO, Braden et al.PharmacoEconomics (Auckland). 2012, Vol 30, Num 11, pp 1067-1084, issn 1170-7690, 18 p.Article

Clinical Report-Health Supervision for Children With Prader-Willi SyndromeMCCANDLESS, Shawn E.Pediatrics (Evanston). 2011, Vol 127, Num 1, pp 195-204, issn 0031-4005, 10 p.Article

Screening in cancer predisposition syndromes: guidelines for the general pediatricianTEPLICK, Alexis; KOWALSKI, Megan; BIEGEL, Jaclyn A et al.European journal of pediatrics. 2011, Vol 170, Num 3, pp 285-294, issn 0340-6199, 10 p.Article

Postnatal screening for Klinefelter syndrome: is there a rationale?HERLIHY, Amy S; GILLAM, Lynn; HALLIDAY, Jane L et al.Acta paediatrica (Oslo). 2011, Vol 100, Num 6, pp 923-933, issn 0803-5253, 11 p.Conference Paper

Voicing the lifeworld: Parental accounts of responsibility in genetic consultations for polycystic kidney disease : Genetics, healthcare, family and kinship in a global perspective: Situated processes of co-constructionCLARKE, Angus; SARANGI, Srikant; VERRIER-JONES, Kate et al.Social science & medicine (1982). 2011, Vol 72, Num 11, pp 1743-1751, issn 0277-9536, 9 p.Article

State of the Art for Genetic Testing of Infertile MenMCLACHLAN, Robert I; O'BRYAN, Moira K.The Journal of clinical endocrinology and metabolism. 2010, Vol 95, Num 3, pp 1013-1024, issn 0021-972X, 12 p.Article

Stopping insulin injections following genetic testing in diabetes: impact on identitySHEPHERD, M.Diabetic medicine. 2010, Vol 27, Num 7, pp 838-843, issn 0742-3071, 6 p.Article

The ethics of direct-to-consumer genetic testingUDESKY, Laurie.Lancet (British edition). 2010, Vol 376, Num 9750, pp 1377-1378, issn 0140-6736, 2 p.Article

Genetic unexceptionalism: Clinician accounts of genetic testing for familial hypercholesterolaemiaWILL, Catherine M; ARMSTRONG, David; MARTEAU, Theresa M et al.Social science & medicine (1982). 2010, Vol 71, Num 5, pp 910-917, issn 0277-9536, 8 p.Article

Risk Information Exposure and Direct-to-Consumer Genetic Testing for BRCA Mutations among Women with a Personal or Family History of Breast or Ovarian CancerGRAY, Stacy W; O'GRADY, Cristin; KARP, Lauren et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 4, pp 1303-1311, issn 1055-9965, 9 p.Article

Should genetic testing be performed in each patient with sporadic pheochromocytoma at presentation?PIGNY, Pascal; CARDOT-BAUTERS, Catherine; DO CAO, Christine et al.European journal of endocrinology. 2009, Vol 160, Num 2, pp 227-231, issn 0804-4643, 5 p.Article

Issues concerning feedback about genetic testing and risk of depressionWILHELM, Kay; MEISER, Bettina; MITCHELL, Philip B et al.British journal of psychiatry (Print). 2009, Vol 194, Num MAI, pp 408-414, issn 0007-1250, 7 p.Article

Sudden cardiac death : Prevalence, pathogenesis, and preventionMONTAGNANA, Martina; LIPPI, Giuseppe; FRANCHINI, Massimo et al.Annals of medicine (Helsinki). 2008, Vol 40, Num 5, pp 360-375, issn 0785-3890, 16 p.Article

Optimisation du test génétique du phéochromocytome : détection des remaniements de grande taille par QMPSF (quantitative multiplex PCR of short fluorescent fragments) = Detection of large rearrangements in the pheochromocytomas genes using QMPSF (quantitative multiplex PCR of short fluorescent fragments): Improvement of genetic testingBURNICHON, N; STROMPF, L; VENISSE, A et al.Archives des maladies du coeur et des vaisseaux. 2007, Vol 100, Num 8, pp 714-714, issn 0003-9683, 1 p.Conference Paper

Cytomics as a new potential for drug discoveryVALET, Günter.Drug discovery today. 2006, Vol 11, Num 17-18, pp 785-791, issn 1359-6446, 7 p.Article